EyePoint Pharmaceuticals
EYPT
#10666
Rank
S$33.03 M
Marketcap
S$0.39
Share price
-4.23%
Change (1 day)
-97.38%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -S$0.4 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are S$2.78 Million. In 2025 the company made an earning of -S$0.3 Billion a decrease over its 2024 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.4 Billion31.84%
2025 -S$0.3 Billion63.24%
2024 -S$0.19 Billion104.29%
2023 -S$89.46 Million-29.88%
2022 -S$0.13 Billion87.2%
2021 -S$68.15 Million38.58%
2020 -S$49.18 Million-24.56%
2019 -S$65.18 Million
2017 -S$29.73 Million22.59%
2016 -S$24.25 Million-8.02%
2015 -S$26.37 Million-296.09%
2014 S$13.44 M-174.02%
2013 -S$18.17 Million37.42%
2012 -S$13.22 Million-56.29%
2011 -S$30.24 Million-1062.38%
2010 S$3.14 M-250.43%
2009 -S$2.09 Million-89.5%
2008 -S$19.9 Million
2005 -S$12.27 Million56.99%
2004 -S$7.82 Million73.7%
2003 -S$4.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.79 Million-99.29% Bahamas
NRC Health
NRC
S$19.04 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA